Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older at the time of giving consent.
- You have been diagnosed with thyroid cancer that no longer responds to radioactive iodine treatment, or is unlikely to respond to it.
- You are scheduled to receive "redifferentiation" drugs (medicines that may help thyroid cancer cells respond to radioactive iodine again) before a planned radioactive iodine scan or treatment, as part of your regular medical care.
- You have never received redifferentiation drugs before outside of a clinical trial, or you received them in a previous clinical trial, but your medical team has now decided to use them as part of your routine care before a radioactive iodine scan or treatment.
- You have previously received redifferentiation drugs as part of your regular care before a radioactive iodine scan or treatment, are willing to share information collected from that time, and are also willing to provide new information going forward from the point of joining this trial.
Who may not be able to join:
- You have thyroid cancer that does not respond to radioactive iodine, and you are receiving redifferentiation drugs before a radioactive iodine scan or treatment as part of a different clinical trial (rather than as routine medical care).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laura Boucai, MD, Memorial Sloan Kettering Cancer Center
Phone: 646-608-3906
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Adverse events will be collected in every visit
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.